BIOMAT Database Logo BIOMAT Database Logo

Suramin decreases circulating levels of insulin-like growth factor-I. 1994

O Sartor, and M R Cooper, and S N Khleif, and C E Myers
Clinical Pharmacology Branch, National Cancer Institute, Bethesda, MD.

UI MeSH Term Description Entries
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D008297 Male Males
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses
D013498 Suramin A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From AMA Drug Evaluations Annual, 1992, p1643) It has also been shown to have potent antineoplastic properties. Germanin,Moranil,Naganin,Naganol,Naphuride,Suramin Sodium,Suramin, Hexasodium Salt,Suramin, Monosodium Salt,Hexasodium Salt Suramin,Monosodium Salt Suramin,Salt Suramin, Hexasodium,Salt Suramin, Monosodium,Sodium, Suramin

Related Publications

O Sartor, and M R Cooper, and S N Khleif, and C E Myers
Intracerebral administration of insulin-like growth factor I decreases circulating growth hormone levels in the fetal pig.
May 1991, Acta endocrinologica,
O Sartor, and M R Cooper, and S N Khleif, and C E Myers
Growth hormone increases and insulin-like growth factor-I decreases circulating lipoprotein(a)
April 1997, European journal of endocrinology,
O Sartor, and M R Cooper, and S N Khleif, and C E Myers
Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis.
February 2002, Cancer research,
O Sartor, and M R Cooper, and S N Khleif, and C E Myers
Determinants of circulating insulin-like growth factor-I.
January 1999, Journal of endocrinological investigation,
O Sartor, and M R Cooper, and S N Khleif, and C E Myers
Exercise and circulating insulin-like growth factor I.
January 2004, Hormone research,
O Sartor, and M R Cooper, and S N Khleif, and C E Myers
Circulating levels of insulin-like growth factor binding protein 3 (IGFBP-3) and insulin-like growth factor I (IGF-I) in perimenopausal women.
November 1994, Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA,
O Sartor, and M R Cooper, and S N Khleif, and C E Myers
Increased circulating levels of insulin-like growth factor-I and decreased circulating levels of insulin-like growth factor binding protein-1 in postmenopausal women with endometrial cancer.
June 1997, Endocrine journal,
O Sartor, and M R Cooper, and S N Khleif, and C E Myers
Circulating levels of insulin-like growth factor-I and risk of ovarian cancer.
October 2002, International journal of cancer,
O Sartor, and M R Cooper, and S N Khleif, and C E Myers
Suramin and serum insulin-like growth factor levels in metastatic cancer patients.
January 1993, Anticancer research,
O Sartor, and M R Cooper, and S N Khleif, and C E Myers
Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin.
January 2005, Cancer,
Copied contents to your clipboard!